Fresenius Medical Care
- Market cap
- 11.01B
- P/E (TTM)i
- 11.14
- P/Bi
- 0.78
- EPSi
- 1.88
- Div yieldi
- 4.13%
- 52W posi
- 20%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Fresenius Medical Care closed at 20.69, down 7.72%. The company carries a market value of roughly 11.01B, the #1333 most valuable US-listed company we track. Trading at a P/E of 11.85, the stock is 34% below its own five-year norm of 17.93. Income-focused holders are looking at a trailing yield of 4.13% here. Wall Street's 3-analyst consensus lands on Sell, with a price target averaging 23.57 (+14% from here). The shares sit 20% of the way up their 52-week range of 19.25 to 26.48.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 4 months.
- Its last 4 Sell calls were followed by roughly flat moves (-1%) three months out.
- Recent price momentum is -17.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 0.5% of float.
- Analyst tilt is Sell.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation A
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 12.2x | Better than 77% |
| Forward P/E | 14.5x | Better than 62% |
| Price / Sales | 0.5x | Better than 94% |
| P/E vs own 5-yr range | 15th pctl | Better than 83% |
Growth C+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 0.4% | Better than 22% |
| Net income CAGR (3Y) | 13.3% | Better than 65% |
| Free cash flow CAGR (3Y) | 6.9% | Better than 45% |
Profitability C-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 25.6% | Better than 22% |
| Operating margin | 9.3% | Better than 33% |
| Net margin | 5.0% | Better than 27% |
| Return on equity | 7.0% | Better than 26% |
| Return on invested capital | 4.9% | Better than 27% |
Momentum C+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -6.4% | Better than 37% |
| 6-month return | 3.6% | Better than 46% |
| 12-month return (ex latest month) | -11.8% | Better than 20% |
| Distance below 52-week high | 14.5% | Better than 62% |
Financial Health B-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.3x | Better than 42% |
| Debt to assets | 34.8% | Better than 44% |
| Interest coverage | 4.9x | Better than 41% |
| Free cash flow / net income | 180.5% | Better than 79% |
Analyst View F
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 0.0% | Better than 0% |
| Upside to average target | 4.1% | Better than 9% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 22.42
- Open
- 22.50
- Day range
- 20.50 - 22.67
- Avg price
- 20.97
- Volume
- 3.24M
- Turnover
- 68.00M
- Turnover ratei
- 0.82%
- Volume ratioi
- 4.91
- Amplitudei
- 9.66%
- 52-week rangei
- 19.25 - 26.48
Valuation
- P/Ei
- 11.00
- P/E (TTM)i
- 11.14
- P/Bi
- 0.78
- EPSi
- 1.88
- Book value / shi
- 26.41
- Net profit
- 1.00B
- Net assets
- 14.06B
Share structure
- Market cap
- 11.01B
- Float capi
- 8.23B
- Shares out
- 532.22M
- Float sharesi
- 397.66M
Dividend & listing
- Div yield (TTM)i
- 4.13%
- Dividend (TTM)
- 0.85
- Listing date
- 1970-01-01
21.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-6.67M net over the window
Short interest
- Shares short
- 2.75M
- % of floati
- 0.52%
- Days to coveri
- 4.69
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Fresenius Medical Care (FMS)?
Fresenius Medical Care last traded at 20.69. The quote on this page refreshes every few seconds while US markets are open.
What is Fresenius Medical Care's market cap?
About 11.01B.
What is the P/E ratio of Fresenius Medical Care?
The trailing twelve-month P/E is 11.14, below its own 5-year average of 17.93 — toward the bottom of its historical range (14.92% percentile). See the Valuation tab for the full history.
Does Fresenius Medical Care pay a dividend?
Yes. The trailing dividend yield is 4.13%. The 2025 payout was up 26.8% from 2024. See the Dividends tab for the full payment history.
Is Fresenius Medical Care a buy according to analysts?
The consensus of 3 analysts is a Sell rating, with an average 12-month price target of 23.57, which implies 13.9% upside from the current price. This is not investment advice.
What is Fresenius Medical Care's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Fresenius Medical Care a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 07:00:11 · For reference only, not investment advice and not tailored to your situation.